Novartis Eyes Gene Therapy Growth With Vedere Acquisition

Paying $150m Upfront

 
• By Kevin Grogan
Eye in an high tech environment
Novartis expanding eye gene therapy presence • Source: Shutterstock

More from Gene Therapies

More from Advanced Therapies